Skip to main content
Premium Trial:

Request an Annual Quote

Across the Board Growth Pushes BD's Q4 Profits up 44 Percent

NEW YORK (GenomeWeb News) — Becton Dickinson today said that fiscal fourth-quarter revenues rose 13 percent as R&D spending increased 22 percent and profit soared 44 percent.
 
Total receipts for the three months ended Sept. 30 increased to $1.65 billion from $1.46 billion year over year.
 
BD said revenues from its Diagnostics segment grew 16 percent to $497.9 million, while Biosciences revenue rose 14 percent to $284.9 million. Revenue from the Medical segment rose 11 percent to $868.3 million.  
 
BD’s R&D spending for the quarter rose to $100.4 million from $82.4 million year over year.
 
The firm’s profits for the quarter increased to $251 million from $174 million in the year-ago period.
 
For full-year 2007, BD reported revenue of $6.4 billion, an 11 percent increase over revenue of $5.7 billion in fiscal 2006. The firm’s 2007 profit was $881.3 million, a 17.1 percent gain on last year’s net earnings of $752.3 million.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.